16 Jul 2024
Reply
Various Finished Formulation needed in China [ENA19990]
A CDMO that focuses on the development of various finished formulations, including creams, emulsions, liquids, solutions, films, and OSDs is looking for various finished formulations for commercial purposes. The required quantity is 20,000 boxes - 30,000 boxes.
1. Capecitabine (500 mg) Tablets or Capsules
2. Dasatinib (50 mg) Tablets or Capsules
3. Enzalutamide (160 mg) Tablets or Capsules
4. Nilotinib (200 mg) Tablets or Capsules
5. Imatinib Mesylate (400 mg) Tablets or Capsules
6. Midostaurin (25 mg) Tablets or Capsules
7. Sunitinib Malate (50 mg) Tablets or Capsules
8. Tofacitinib XR (11 mg) Tablets or Capsules
9. Pazopanib (400 mg) Tablets or Capsules
10. Adagrasib (200 mg) Tablets or Capsules
11. Apalutamide (60 mg) Tablets or Capsules
12. Fingolimod (0.5 mg) Tablets or Capsules
13. Nintedanib (150 mg) Tablets or Capsules
14. Valganciclovir (450 mg) Tablets or Capsules
1. Capecitabine (500 mg) Tablets or Capsules
2. Dasatinib (50 mg) Tablets or Capsules
3. Enzalutamide (160 mg) Tablets or Capsules
4. Nilotinib (200 mg) Tablets or Capsules
5. Imatinib Mesylate (400 mg) Tablets or Capsules
6. Midostaurin (25 mg) Tablets or Capsules
7. Sunitinib Malate (50 mg) Tablets or Capsules
8. Tofacitinib XR (11 mg) Tablets or Capsules
9. Pazopanib (400 mg) Tablets or Capsules
10. Adagrasib (200 mg) Tablets or Capsules
11. Apalutamide (60 mg) Tablets or Capsules
12. Fingolimod (0.5 mg) Tablets or Capsules
13. Nintedanib (150 mg) Tablets or Capsules
14. Valganciclovir (450 mg) Tablets or Capsules
vp@vamalifecare.com
We can supply with dossiers and also give commercial supply from India- Eu-GMP approved facility
13:21, 02 Aug 2024
